Event Date/Time: Nov 14, 2005
End Date/Time: Nov 15, 2005
IBC’s Inaugural Metabolic Profiling focuses on how metabolomic technology can bring successful drugs to the market at a lower cost and in less time than traditional technologies. Hear featured presentations from Dr. David Balshaw about metabolomics and the NIH Roadmap from Dr. Rima Kaddurah Daouk about the global perspectives on metabolomics. Hear how pharmaceutical companies like Pfizer Global Research & Discovery, AstraZeneca R&D, Novo Nordisk A/S, GSK, and Hoffmann-La Roche are using metabolic profiling in their drug discovery efforts. Also, hear about the latest breakthroughs from leading academic institutes including Imperial College London, Duke University Medical Center and the University of North Carolina at Chapel Hill. For further details and to register, visit: http://www.IBCLifeSciences.com/3150 or call +1 (508) 616-5550.